Nephros, Inc.NEPHNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
6.84%
↑ 119% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-36.28%
Historical baseline
PeriodValueYoY Change
TTM6.84%+327.0%
20241.60%+116.8%
2023-9.54%+74.2%
2022-36.95%-51.6%
2021-24.38%+50.4%
2020-49.15%-68.8%
2019-29.12%+46.3%
2018-54.21%+0.6%
2017-54.56%+51.9%
2016-113.36%-